Biliary Tract Cancers, Version 2.2023 Featured Updates to the NCCN Guidelines

被引：96

作者：

Benson, Al B., III ^{[1
]}

D'Angelica, Michael I. ^{[2
]}

Abrams, Thomas ^{[3
]}

Abbott, Daniel E. ^{[4
]}

Ahmed, Aijaz ^{[5
]}

Anaya, Daniel A. ^{[6
]}

Anders, Robert ^{[7
]}

Are, Chandrakanth ^{[8
]}

Bachini, Melinda ^{[9
]}

Binder, David ^{[10
]}

Borad, Mitesh ^{[11
]}

Bowlus, Christopher ^{[12
]}

Brown, Daniel ^{[13
]}

Burgoyne, Adam ^{[14
]}

Castellanos, Jason ^{[15
]}

Chahal, Prabhleen ^{[16
,17
]}

Cloyd, Jordan ^{[18
,19
]}

Covey, Anne M. ^{[2
]}

Glazer, Evan S. ^{[20
]}

Hawkins, William G. ^{[21
,22
]}

Iyer, Renuka ^{[23
]}

Jacob, Rojymon ^{[24
]}

Jennings, Lawrence ^{[1
]}

Kelley, R. Kate ^{[25
]}

Kim, Robin ^{[26
]}

Levine, Matthew ^{[27
]}

Palta, Manisha ^{[28
]}

Park, James O. ^{[29
]}

Raman, Steven ^{[30
]}

Reddy, Sanjay ^{[15
]}

Ronnekleiv-Kelly, Sean ^{[4
]}

Sahai, Vaibhav ^{[31
]}

Singh, Gagandeep ^{[32
]}

Stein, Stacey ^{[33
]}

Turk, Anita ^{[34
]}

Vauthey, Jean-Nicolas ^{[35
]}

Venook, Alan P. ^{[25
]}

Yopp, Adam ^{[36
]}

McMillian, Nicole ^{[37
]}

Schonfeld, Ryan ^{[37
]}

Hochstetler, Cindy ^{[37
]}

机构：

[1] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA

[2] Mem Sloan Kettering Canc Ctr, New York, NY USA

[3] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA

[4] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53706 USA

[5] Stanford Canc Inst, Stanford, CA USA

[6] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[7] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA

[8] Fred & Pamela Buffett Canc Ctr, Omaha, NE USA

[9] Cholangiocarcinoma Fdn, Herriman, UT USA

[10] Univ Colorado, Ctr Canc, Boulder, CO 80309 USA

[11] Mayo Clin, Comprehens Canc Ctr, Rochester, MN USA

[12] Univ Calif Davis, Comprehens Canc Ctr, Davis, CA USA

[13] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[14] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA USA

[15] Fox Chase Canc Ctr, Philadelphia, PA USA

[16] Univ Hosp Seidman Canc Ctr, Case Comprehens Canc Ctr, Cleveland, OH USA

[17] Cleveland Clin, Taussig Canc Inst, Cleveland, OH USA

[18] Ohio State Univ, Ctr Comprehens Canc, James Canc Hosp, Columbus, OH 43210 USA

[19] Solove Res Inst, Columbus, OH USA

[20] Univ Tennessee, Hlth Sci Ctr, Knoxville, TN 37996 USA

[21] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO USA

[22] Washington Univ, Sch Med, St Louis, MO USA

[23] Roswell Park Comprehens Canc Ctr, Buffalo, NY USA

[24] UAB, ONeal Comprehens Canc Ctr, Birmingham, AL USA

[25] UCSF, HelenDiller Family Comprehens Canc Ctr, San Francisco, CA USA

[26] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA

[27] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[28] Duke Canc Inst, Durham, NC USA

[29] Fred Hutchinson Canc Res Ctr, Seattle, WA USA

[30] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA

[31] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA

[32] City Hope Natl Med Ctr, Duarte, CA USA

[33] Yale Canc Hosp, Smilow Canc Hosp, New Haven, CT USA

[34] Indiana Univ, Melvin & Bren Simon Comprehens Canc Ctr, Bloomington, IN 47405 USA

[35] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[36] UT Southwestern Simmons Comprehens Canc Ctr, Dallas, TX USA

[37] Natl Comprehens Canc Network, Plymouth Meeting, PA USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2023年 / 21卷 / 07期

关键词：

POSITIVE SOLID TUMORS; OPEN-LABEL; PHASE; 1/2; FUSION; CHOLANGIOCARCINOMA; MULTICENTER; EFFICACY; CHEMOTHERAPY; CABOZANTINIB; COMBINATION;

D O I：

10.6004/jnccn.2023.0035

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In 2023, the NCCN Guidelines for Hepatobiliary Cancers were divided into 2 separate guidelines: Hepatocellular Carcinoma and Biliary Tract Cancers. The NCCN Guidelines for Biliary Tract Cancers provide recommendations for the evaluation and comprehensive care of patients with gallbladder cancer, intrahepatic cholangiocarcinoma, and extrahepatic cholangiocarcinoma. The multidisciplinary panel of experts meets at least on an annual basis to review requests from internal and external entities as well as to evaluate new data on current and emerging therapies. These Guidelines Insights focus on some of the recent updates to the NCCN Guidelines for Biliary Tract Cancers as well as the newly published section on principles of molecular testing.

引用

页码：695 / 704

页数：10

共 39 条

[1] Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma [J].

Abou-Alfa, G. K. ;

Meyer, T. ;

Cheng, A. -L. ;

El-Khoueiry, A. B. ;

Rimassa, L. ;

Ryoo, B. -Y. ;

Cicin, I. ;

Merle, P. ;

Chen, Y. H. ;

Park, J. -W. ;

Blanc, J. -F. ;

Bolondi, L. ;

Klumpen, H. -J. ;

Chan, S. L. ;

Zagonel, V. ;

Pressiani, T. ;

Ryu, M. -H. ;

Venook, A. P. ;

Hessel, C. ;

Borgman-Hagey, A. E. ;

Schwab, G. ;

Kelley, R. K. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (01) :54-63

[2] Ivosidenib in IDH1-mutant, chemotherapy-refractory Croatia& cholangiocarcinoma (ClarlDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study [J].

Abou-Alfa, Ghassan K. ;

Macarulla, Teresa ;

Javle, Milind M. ;

Kelley, Robin K. ;

Lubner, Sam J. ;

Adeva, Jorge ;

Cleary, James M. ;

Catenacci, Daniel V. ;

Borad, Mitesh J. ;

Bridgewater, John ;

Harris, William P. ;

Murphy, Adrian G. ;

Oh, Do-Youn ;

Whisenant, Jonathan ;

Lowery, Maeve A. ;

Goyal, Lipika ;

Shroff, Rachna T. ;

El-Khoueiry, Anthony B. ;

Fan, Bin ;

Wu, Bin ;

Chamberlain, Christina X. ;

Jiang, Liewen ;

Gliser, Camelia ;

Pandya, Shuchi S. ;

Valle, Juan W. ;

Zhu, Andrew X. .

LANCET ONCOLOGY, 2020, 21 (06) :796-807

[3] Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study [J].

Abou-Alfa, Ghassan K. ;

Sahai, Vaibhav ;

Hollebecque, Antoine ;

Vaccaro, Gina ;

Melisi, Davide ;

Al-Rajabi, Raed ;

Paulson, Andrew S. ;

Borad, Mitesh J. ;

Gallinson, David ;

Murphy, Adrian G. ;

Oh, Do-Youn ;

Dotan, Efrat ;

Catenacci, Daniel, V ;

Van Cutsem, Eric ;

Ji, Tao ;

Lihou, Christine F. ;

Zhen, Huiling ;

Feliz, Luis ;

Vogel, Arndt .

LANCET ONCOLOGY, 2020, 21 (05) :671-684

[4] A Novel NIPBL-NACC1 Gene Fusion Is Characteristic of the Cholangioblastic Variant of Intrahepatic Cholangiocarcinoma [J].

Argani, Pedram ;

Palsgrove, Doreen N. ;

Anders, Robert A. ;

Smith, Steven C. ;

Saoud, Carla ;

Kwon, Regina ;

Voltaggio, Lysandra ;

Assarzadegan, Naziheh ;

Oshima, Kiyoko ;

Rooper, Lisa ;

Matoso, Andres ;

Zhang, Lei ;

Cantarel, Brandi L. ;

Gagan, Jeffrey ;

Antonescu, Cristina R. .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2021, 45 (11) :1550-1560

[5] Testing for ROS1, ALK, MET, and HER2 rearrangements and amplifications in a large series of biliary tract adenocarcinomas [J].

Augustin, Jeremy ;

Gabignon, Caroline ;

Scriva, Aurelie ;

Menu, Laetitia ;

Calmel, Claire ;

Scatton, Olivier ;

Paye, Francois ;

Flejou, Jean-Francois ;

Praz, Francoise ;

Cervera, Pascale ;

Wendum, Dominique .

VIRCHOWS ARCHIV, 2020, 477 (01) :33-45

[6] Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials [J].

Doebele, Robert C. ;

Drilon, Alexander ;

Paz-Ares, Luis ;

Siena, Salvatore ;

Shaw, Alice T. ;

Farago, Anna F. ;

Blakely, Collin M. ;

Seto, Takashi ;

Cho, Byung Chul ;

Tosi, Diego ;

Besse, Benjamin ;

Chawla, Sant P. ;

Bazhenova, Lyudmila ;

Krauss, John C. ;

Chae, Young Kwang ;

Barve, Minal ;

Garrido-Laguna, Ignacio ;

Liu, Stephen V. ;

Conkling, Paul ;

John, Thomas ;

Fakih, Marwan ;

Sigal, Darren ;

Loong, Herbert H. ;

Buchschacher, Gary L., Jr. ;

Garrido, Pilar ;

Nieva, Jorge ;

Steuer, Conor ;

Overbeck, Tobias R. ;

Bowles, Daniel W. ;

Fox, Elizabeth ;

Riehl, Todd ;

Chow-Maneval, Edna ;

Simmons, Brian ;

Cui, Na ;

Johnson, Ann ;

Eng, Susan ;

Wilson, Timothy R. ;

Demetri, George D. .

LANCET ONCOLOGY, 2020, 21 (02) :271-282

[7] Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children [J].

Drilon, A. ;

Laetsch, T. W. ;

Kummar, S. ;

DuBois, S. G. ;

Lassen, U. N. ;

Demetri, G. D. ;

Nathenson, M. ;

Doebele, R. C. ;

Farago, A. F. ;

Pappo, A. S. ;

Turpin, B. ;

Dowlati, A. ;

Brose, M. S. ;

Mascarenhas, L. ;

Federman, N. ;

Berlin, J. ;

El-Deiry, W. S. ;

Baik, C. ;

Deeken, J. ;

Boni, V. ;

Nagasubramanian, R. ;

Taylor, M. ;

Rudzinski, E. R. ;

Meric-Bernstam, F. ;

Sohal, D. P. S. ;

Ma, P. C. ;

Raez, L. E. ;

Hechtman, J. F. ;

Benayed, R. ;

Ladanyi, M. ;

Tuch, B. B. ;

Ebata, K. ;

Cruickshank, S. ;

Ku, N. C. ;

Cox, M. C. ;

Hawkins, D. S. ;

Hong, D. S. ;

Hyman, D. M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (08) :731-739

[8] Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma [J].

Goyal, Lipika ;

Meric-Bernstam, Funda ;

Hollebecque, Antoine ;

Valle, Juan W. ;

Morizane, Chigusa ;

Karasic, Thomas B. ;

Abrams, Thomas A. ;

Furuse, Junji ;

Kelley, Robin K. ;

Cassier, Philippe A. ;

Kluempen, Heinz-Josef ;

Chang, Heung-Moon ;

Chen, Li-Tzong ;

Tabernero, Josep ;

Oh, Do-Youn ;

Mahipal, Amit ;

Moehler, Markus ;

Mitchell, Edith P. ;

Komatsu, Yoshito ;

Masuda, Kunihiro ;

Ahn, Daniel ;

Epstein, Robert S. ;

Halim, Abdel-Baset ;

Fu, Yao ;

Salimi, Tehseen ;

Wacheck, Volker ;

He, Yaohua ;

Liu, Mei ;

Benhadji, Karim A. ;

Bridgewater, John A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (03) :228-239

[9] A phase 2 and biomarker study of cabozantinib in patients with advanced cholangiocarcinoma [J].

Goyal, Lipika ;

Zheng, Hui ;

Yurgelun, Matthew B. ;

Abrams, Thomas A. ;

Allen, Jill N. ;

Cleary, James M. ;

Knowles, Michelle ;

Regan, Eileen ;

Reardon, Amanda ;

Khachatryan, Anna ;

Jain, Rakesh K. ;

Nardi, Valentina ;

Borger, Darrell R. ;

Duda, Dan G. ;

Zhu, Andrew X. .

CANCER, 2017, 123 (11) :1979-1988

[10] Survey of Tyrosine Kinase Signaling Reveals ROS Kinase Fusions in Human Cholangiocarcinoma [J].

Gu, Ting-Lei ;

Deng, Xiaxing ;

Huang, Feizhou ;

Tucker, Meghan ;

Crosby, Katherine ;

Rimkunas, Victoria ;

Wang, Yi ;

Deng, Gang ;

Zhu, Lei ;

Tan, Zhiping ;

Hu, Yerong ;

Wu, Chunlin ;

Nardone, Julie ;

MacNeill, Joan ;

Ren, Jianmin ;

Reeves, Cynthia ;

Innocenti, Gregory ;

Norris, Brett ;

Yuan, Jin ;

Yu, Jian ;

Haack, Herbert ;

Shen, Baiyong ;

Peng, Chenghong ;

Li, Hongwei ;

Zhou, Xinmin ;

Liu, Xunyang ;

Rush, John ;

Comb, Michael J. .

PLOS ONE, 2011, 6 (01)

← 1 2 3 4 →